328130 — Lunit Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapSucker Stock

Annual cashflow statement for Lunit, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-73,676	-39,118	-36,798	-82,421	-47,390
Depreciation
Amortisation
Non-Cash Items	33,965	-5,085	-219	27,064	-12,512
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital	4,920	-11,856	-3,228	-18,037	-5,581
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-32,725	-53,019	-36,473	-65,696	-55,175
Capital Expenditures	-753	-3,963	-1,591	-6,674	-9,633
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-59,452	20,884	-144,230	-79,750	7,217
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-60,205	16,921	-145,821	-86,424	-2,417
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	99,924	34,546	199,573	171,259	19,793
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	7,018	-1,243	17,157	20,715	-38,259